The current context of a cannabis regulatory change: Analysis of a Peruvian course

Authors

Keywords:

cannabis, medical marijuana, patients, Peru.

Abstract

This article presents an analysis of the technical opinions expressed during the update course "Medicinal use of cannabis: An informed perspective for adequate regulation" held from June to July 2022. The course was organized by the National Center for Intercultural Health of the National Institute of Health of Peru with the objective of gathering specialized information and thus developing an institutional technical opinion on the proposal of modifications to the cannabis regulation issued by the General Directorate of Medicines and Drugs Supplies. The new regulation must include the artisanal production of cannabis and derivatives through patient associations according to the mandate of Law 31312, which modifies Law 30681, thus including this activity. During the event, various topics related to the use of cannabis were discussed, including traditional and therapeutic uses, scientific evidence, history of prohibition, botany, biochemistry, pharmacology, toxicological risks, national regulation, regulatory experience in Uruguay, public health and access. As well as criminal effects, situation of access to cannabis to the patient, quality control, productive experience of patients associations in Brazil.

Downloads

Download data is not yet available.

Author Biographies

Pedro Wong-Salgado, CANNAVITAL Clínica Especializada en Terapias con Cannabinoides. Lima, Perú.

QF

MSc

Marcia M. Moya-Salazar, Nesh Hubbs. Cannabis and Stone Unit. Lima, Perú.

QF

MSc

Eliane Goicochea-Palomino, Universidad Tecnológica del Perú. Facultad de Ciencias de la Salud. Lima, Perú.

BSc

Jeel Moya-Salazar, Universidad Privada del Norte. Facultad de Ciencias de la Salud. Lima, Perú.

MPH

PhD

References

1. El Comercio. San Miguel: PNP halló laboratorio de marihuana en departamento. Diario el Comercio. Editorial. 2017 [acceso: 20/02/2022]. Disponible en: https://elcomercio.pe/lima/san-miguel-pnp-hallo-laboratorio-marihuana-departamento-163565-noticia/

2. Ministerio del Interior. Decreto Ley N° 22095. Gobierno del Perú. [acceso: 20/02/2022]. Disponible en: https://www.gob.pe/institucion/corahperu/normas-legales/850797-22095

3. El Comercio. Marihuana medicinal: archivarían denuncia contra 3 personas. [acceso: 20/02/2022]. Diario El Comercio. 2017 [acceso: 20/02/2022]. Disponible en: https://elcomercio.pe/lima/sucesos/marihuana-medicinal-denuncia-3-personas-seria-archivada-noticia-467452-noticia/

4. Sulak D, Saneto R, Goldstein B. The current status of artisanal cannabis for the treatment of epilepsy in the United States. Epilepsy Behav. 2017; 70(Pt B): 328-333. DOI: 10.1016/j.yebeh.2016.12.032.

5. Food and Drug Administration. EPIDIOLEX® (cannabidiol) oral solution, CX [pending DEA scheduling action]. [acceso: 20/02/2022]. Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf

6. Congreso de la República. Ley Nº 30681. Ley que regula el uso medicinal y terapéutico del cannabis y sus derivados. Gobierno del Perú. 2017 [acceso: 20/02/2022]. Disponible en: https://busquedas.elperuano.pe/normaslegales/ley-que-regula-el-uso-medicinal-y-terapeutico-del-cannabis-y-ley-n-30681-1587374-1/

7. Ministerio de Salud. Decreto Supremo N° 005-2019-SA. Gobierno del Perú. 2019 [acceso: 20/02/2022]. Disponible en: https://www.gob.pe/institucion/minsa/normas-legales/262787-005-2019-sa

8. Paucar AJ. Informe: Más del 70 % de pacientes accede a cannabis por vías no reguladas en Perú. Sativa Info. 2022 [acceso: 20/02/2022]. Disponible en: https://www.sativainfo.pe/post/informe-cannabis-medicinal-peru-acceso-real-cifras-oficiales-minsa

9. La República. El 70 % de pacientes de cannabis no compra su medicina en farmacias y boticas debido a trabas. Sociedad. 2022 [acceso: 20/02/2022]. Disponible en: https://larepublica.pe/sociedad/2022/05/26/cannabis-el-70-de-pacientes-no-compra-su-medicina-en-farmacias-o-boticas-autorizadas-debido-a-trabas-marihuana-minsa-atmp/

10. Redacción Gestión. DIGEMID pone a la venta cannabis medicinal en concentraciones de 10% y 5%. Diario Gestión, Perú. 2021 [acceso: 20/02/2022]. Disponible en: https://gestion.pe/peru/digemid-pone-a-la-venta-cannabis-medicinal-en-dos-concentraciones-nndc-noticia/

11. Congreso de la República. Ley Nº 31312. Ley que incorpora y modifica artículos de la ley 30681, ley que regula el uso medicinal y terapéutico del cannabis y sus derivados. Gobierno del Perú. 2021 [acceso: 20/02/2022]. Disponible en: [acceso: 20/02/2022]. Disponible en: https://busquedas.elperuano.pe/normaslegales/ley-que-incorpora-y-modifica-articulos-de-la-ley-30681-ley-ley-n-31312-1976352-1/#:~:text=Se%20autorizan%20el%20uso%20informado,terap%C3%A9uticos%2C-%20de%20acuerdo%20con%20las

12. Ministerio de Salud. Resolución Ministerial N° 355-2022-MINSA. Gobierno del Perú. 2022 [acceso: 20/02/2022]. Disponible en: https://www.gob.pe/institucion/minsa/normas-legales/2991538-355-2022-minsa

13. TNI. Cannabis in Latin America. The Green Wave and Challenges for Regulation. Transnational Institute. Drug Law Reform Cannabis. Regions Latin America and the Caribbean. 2020 [acceso: 20/02/2022]. Disponible en: https://www.tni.org/en/article/cannabis-in-latin-america

14. Cusihuaman S, Moya-Salazar J, Wong-Salgado P, Moya-Salazar MM, Cañari B, Chicoma-Flores K, et al. Changes in High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL) and Cholesterol Concentration in Heavy Cannabis Users: A Single-Centre Study in Cusco, Peru. Processes. 2022; 10(8):1597. DOI 10.3390/pr10081597

15. Botto C, Paz T, Wong-Salgado P, Moya-Salazar J. Effectiveness of In-house medical cannabis for refractory drug-resistant epilepsy in children and adolescents: a retrospective-cohort study in Peru. BMJ Peadiatric Open. 2023; in press.

16. Bonnett M. Historical Overview on the Evolution and Legislation of Cannabis in Latin America. Meritas. Article. 2023 [acceso: 20/02/2022]. Disponible en: https://www.meritas.org/insight/article/Historical-Overview-on-the-evolution-and-legislation-of-cannabis-in-latin-america#:~:text=In%20the%20region%2C%20medicinal%20use,recreational%20u-se%20permitted%20for%20adults .

17. Congreso de la Republica. Ley 30681. Ley que regula el uso medicinal y terapéutico del cannabis y sus derivados. Gobierno del Perú. [acceso: 20/02/2022]. Disponible en: https://busquedas.elperuano.pe/normaslegales/ley-que-regula-el-uso-medicinal-y-terapeutico-del-cannabis-y-ley-n-30681-1587374-1/

Downloads

Published

2023-07-24

How to Cite

1.
Wong-Salgado P, Moya-Salazar MM, Goicochea-Palomino E, Moya-Salazar J. The current context of a cannabis regulatory change: Analysis of a Peruvian course. Rev Cubana Med Milit [Internet]. 2023 Jul. 24 [cited 2025 Jun. 14];52(3):e02302434. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/2434

Issue

Vol. 52 No. 3 (2023): July - september

Section

Opinion Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.